Campbell & Co. Investment Adviser »

Amylyx Pharmaceuticals shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2025-12-31 $952k 79k 12.08
2025-09-30 $333k 25k 13.59

More positions owned by Campbell & Co. Investment Adviser

Itt Common Stock (ITT)
Cheniere Energy Common Stock (LNG)
United Rentals Common Stock (URI)
BHP Group Adr (BHP)
Cullen/Frost Bankers Common Stock (CFR)
Pool Corp Common Stock (POOL)
Ameris Bancorp Common Stock (ABCB)
Bank of America Corp Common Stock (BAC)
Aecom Common Stock (ACM)
Associated Banc-Corp Common Stock (ASB)
DTE Energy Common Stock (DTE)
Netflix Common Stock (NFLX)
Allstate Corp/The Common Stock (ALL)
Labcorp Holdings Common Stock (LH)
Southwest Airlines Common Stock (LUV)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Amylyx Pharmaceuticals

FMR
BlackRock
Perceptive Advisors
Adage Capital Partners GP
TCG Crossover Management
Vanguard Group
Commodore Capital
Saturn V Capital Management
First Light Asset Management
Goldman Sachs Group
Henderson Group
Driehaus Capital Management
Geode Capital Management
Almitas Capital
State Street Corporation

View all funds holding Amylyx Pharmaceuticals